Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool

Launched by OHSU KNIGHT CANCER INSTITUTE · Jun 2, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at a special conversation tool designed to help patients with lung cancer make better decisions about their treatment options. The goal is to understand what information patients need to feel confident in their choices, especially for those who may find medical information difficult to understand. By focusing on how patients choose their treatment, the researchers hope to improve communication between doctors and patients, ensuring everyone is on the same page.

To participate in this study, you need to be an adult with a suspected diagnosis of lung cancer, able to speak English, and expected to live at least six more months. Participants will engage in discussions about their treatment options and share their experiences, which will help doctors learn how to better support patients in making these important decisions. If you or someone you know is eligible, this study could be a great opportunity to contribute to improving healthcare communication for lung cancer patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • AIM 1: Suspected lung cancer
• • AIM 1: English fluency
• • AIM 1: \> 6-month life expectancy
• • AIM 1: Score of ≥ 3 on the cognitive impairment screener
• • AIM 2 PARTICIPANTS: Participation in Aim 1
• • AIM 2 CLINICIANS: Discussing lung cancer treatment decisions with Aim 1 participants